FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2127129900> ?p ?o ?g. }

• W2127129900 endingPage "2401" @default.
• W2127129900 startingPage "2395" @default.
• W2127129900 abstract "Crizotinib, an inhibitor of anaplastic lymphoma kinase (ALK), has also recently shown efficacy in the treatment of lung cancers with ROS1 translocations. Resistance to crizotinib developed in a patient with metastatic lung adenocarcinoma harboring a CD74-ROS1 rearrangement who had initially shown a dramatic response to treatment. We performed a biopsy of a resistant tumor and identified an acquired mutation leading to a glycine-to-arginine substitution at codon 2032 in the ROS1 kinase domain. Although this mutation does not lie at the gatekeeper residue, it confers resistance to ROS1 kinase inhibition through steric interference with drug binding. The same resistance mutation was observed at all the metastatic sites that were examined at autopsy, suggesting that this mutation was an early event in the clonal evolution of resistance. (Funded by Pfizer and others; ClinicalTrials.gov number, NCT00585195.)." @default.
• W2127129900 created "2016-06-24" @default.
• W2127129900 creator A5004383407 @default.
• W2127129900 creator A5006518535 @default.
• W2127129900 creator A5011207225 @default.
• W2127129900 creator A5013479170 @default.
• W2127129900 creator A5025583232 @default.
• W2127129900 creator A5031081898 @default.
• W2127129900 creator A5031124571 @default.
• W2127129900 creator A5035582870 @default.
• W2127129900 creator A5037066533 @default.
• W2127129900 creator A5040093136 @default.
• W2127129900 creator A5052578824 @default.
• W2127129900 creator A5056275493 @default.
• W2127129900 creator A5056520253 @default.
• W2127129900 creator A5061648315 @default.
• W2127129900 creator A5064266279 @default.
• W2127129900 creator A5071037763 @default.
• W2127129900 creator A5072389805 @default.
• W2127129900 creator A5074923974 @default.
• W2127129900 creator A5080311196 @default.
• W2127129900 creator A5081227348 @default.
• W2127129900 creator A5086249998 @default.
• W2127129900 creator A5089644945 @default.
• W2127129900 date "2013-06-20" @default.
• W2127129900 modified "2023-10-18" @default.
• W2127129900 title "Acquired Resistance to Crizotinib from a Mutation in <i>CD74</i>–<i>ROS1</i>" @default.
• W2127129900 cites W1980497534 @default.
• W2127129900 cites W1997476230 @default.
• W2127129900 cites W1999614615 @default.
• W2127129900 cites W2003984225 @default.
• W2127129900 cites W2043696829 @default.
• W2127129900 cites W2055402151 @default.
• W2127129900 cites W2066417528 @default.
• W2127129900 cites W2096156234 @default.
• W2127129900 cites W2104694028 @default.
• W2127129900 cites W2104830962 @default.
• W2127129900 cites W2111254482 @default.
• W2127129900 cites W2113327188 @default.
• W2127129900 cites W2116922255 @default.
• W2127129900 cites W2130488043 @default.
• W2127129900 cites W2131876608 @default.
• W2127129900 cites W2134787029 @default.
• W2127129900 cites W2144621689 @default.
• W2127129900 cites W2148332636 @default.
• W2127129900 cites W2150575159 @default.
• W2127129900 cites W2161821474 @default.
• W2127129900 cites W2168691181 @default.
• W2127129900 cites W2170144893 @default.
• W2127129900 cites W2329648702 @default.
• W2127129900 cites W2566863750 @default.
• W2127129900 doi "https://doi.org/10.1056/nejmoa1215530" @default.
• W2127129900 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3878821" @default.
• W2127129900 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24047072" @default.
• W2127129900 hasPublicationYear "2013" @default.
• W2127129900 type Work @default.
• W2127129900 sameAs 2127129900 @default.
• W2127129900 citedByCount "322" @default.
• W2127129900 countsByYear W21271299002013 @default.
• W2127129900 countsByYear W21271299002014 @default.
• W2127129900 countsByYear W21271299002015 @default.
• W2127129900 countsByYear W21271299002016 @default.
• W2127129900 countsByYear W21271299002017 @default.
• W2127129900 countsByYear W21271299002018 @default.
• W2127129900 countsByYear W21271299002019 @default.
• W2127129900 countsByYear W21271299002020 @default.
• W2127129900 countsByYear W21271299002021 @default.
• W2127129900 countsByYear W21271299002022 @default.
• W2127129900 countsByYear W21271299002023 @default.
• W2127129900 crossrefType "journal-article" @default.
• W2127129900 hasAuthorship W2127129900A5004383407 @default.
• W2127129900 hasAuthorship W2127129900A5006518535 @default.
• W2127129900 hasAuthorship W2127129900A5011207225 @default.
• W2127129900 hasAuthorship W2127129900A5013479170 @default.
• W2127129900 hasAuthorship W2127129900A5025583232 @default.
• W2127129900 hasAuthorship W2127129900A5031081898 @default.
• W2127129900 hasAuthorship W2127129900A5031124571 @default.
• W2127129900 hasAuthorship W2127129900A5035582870 @default.
• W2127129900 hasAuthorship W2127129900A5037066533 @default.
• W2127129900 hasAuthorship W2127129900A5040093136 @default.
• W2127129900 hasAuthorship W2127129900A5052578824 @default.
• W2127129900 hasAuthorship W2127129900A5056275493 @default.
• W2127129900 hasAuthorship W2127129900A5056520253 @default.
• W2127129900 hasAuthorship W2127129900A5061648315 @default.
• W2127129900 hasAuthorship W2127129900A5064266279 @default.
• W2127129900 hasAuthorship W2127129900A5071037763 @default.
• W2127129900 hasAuthorship W2127129900A5072389805 @default.
• W2127129900 hasAuthorship W2127129900A5074923974 @default.
• W2127129900 hasAuthorship W2127129900A5080311196 @default.
• W2127129900 hasAuthorship W2127129900A5081227348 @default.
• W2127129900 hasAuthorship W2127129900A5086249998 @default.
• W2127129900 hasAuthorship W2127129900A5089644945 @default.
• W2127129900 hasBestOaLocation W21271299001 @default.
• W2127129900 hasConcept C104317684 @default.
• W2127129900 hasConcept C117643217 @default.
• W2127129900 hasConcept C121608353 @default.
• W2127129900 hasConcept C126322002 @default.
• W2127129900 hasConcept C143998085 @default.

• next